[Artificial Intelligence-Based Side Effects Questionnaire System for Outpatient of Cancer Drug Therapy-Realization of Reform of Work Styles for Healthcare Professionals and Improvement of Quality of Life for Patients].

The number of registered cancer cases is 1.1 million in Japan in 2021. Cancer incidence and mortality rates are increasing due to the aging population, and one in two people will be diagnosed with cancer at least once in their lifetime. Cancer drug therapy is not only used as a stand-alone but also used in combination with surgical treatment and radiotherapy in many cases and it is applied in 30.5% of all first-line treatments. This paper describes the research and development of artificial intelligence(AI)-based side effects questionnaire system for patients undergoing cancer drug therapy, which has been conducted in collaboration with The Cancer Institute Hospital of JFCR, under the Innovative Artificial Intelligence(AI)Hospital Program(AI Hospital). AI Hospital is one of twelve in the 2nd term of Cross-ministerial Strategic Innovation Promotion Program(SIP)led by Cabinet Office in Japan since 2018. AI-based side effects questionnaire system is effective in reducing the amount of time that pharmacotherapy pharmacists spend on each patient from 10 minutes to 1 minute, and the implementation rate of interviewing patients who needed to be interviewed was 100%. We have also conducted research and development for the digitalization of patient consent(eConsent), which is required in various situations at medical institutions, such as examination, treatment, and hospitalization and for safe and secure delivery of image diagnosis services using AI by utilizing a healthcare AI platform. By combining these digital technologies, we would like to accelerate the digital transformation of the medical field, which will contribute to reforming the work styles of medical professionals and improving patient quality of life(QoL).